Finance

Lists
BRKR:NASDAQ
Bruker Corp
USD 56,54
+1,69%
(+0,94) 1D
USD 56,54
0,00% (0,00)
After hours
Closed: 15 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRKR...
Open
USD 54,97
High
USD 57,01
Low
USD 54,44
Mkt. cap
8,61 mjd
Avg. vol.
2,28 m
Volume
0,00
Dividend
0,35%
Quarterly dividend
USD 0,05
Ex-dividend date
21 Sep. 2026
52-wk high
USD 66,98
52-wk low
USD 32,36
EPS
-USD 0,70
Beta
1,22
Shares outstanding
152,36 m
No. of employees
11 k
Open
USD 54,97
High
USD 57,01
Low
USD 54,44
Mkt. cap
8,61 mjd
Avg. vol.
2,28 m
Volume
0,00
Dividend
0,35%
Quarterly dividend
USD 0,05
Ex-dividend date
21 Sep. 2026
52-wk high
USD 66,98
52-wk low
USD 32,36
EPS
-USD 0,70
Beta
1,22
Shares outstanding
152,36 m
No. of employees
11 k
News stories
From web sources and news partners
Profile
Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize. Wikipedia
About Bruker Corp
CEOFrank Laukien
Employees11,1 k
Founded1960
HeadquartersBillerica, Massachusetts, Verenigde State van Amerika
SectorHealth care
Websitebruker.com
Analyst ratings
Based on 10 analysts giving stock ratings to BRKR in the past 3 months
Buy
Buy
5
Hold
4
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BRKR in the last 3 months.
Highest
Current USD 56,54
USD 80,00 (+41,49%)
Average
USD 61,33 (+8,47%)
Lowest
USD 50,00 (-11,57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Casey Woodring
J.P. Morgan
Hold
Downgraded
USD 60,00
+6,1%
10/14/2026
Daniel Brennan
TD Cowen
Hold
Maintained
USD 62,00
+9,7%
10/13/2026
Luke Sergott
Barclays
Buy
Maintained
USD 70,00
+23,8%
10/07/2026
Unknown Analyst
Goldman Sachs
Sell
Maintained
USD 50,00
-11,6%
10/05/2026
Evie Koslosky
Goldman Sachs
Sell
Maintained
USD 50,00
-11,6%
10/05/2026
Subbu Nambi
Guggenheim
Buy
Maintained
USD 72,00
+27,3%
10/01/2026
Puneet Souda
Leerink Partners
Buy
Maintained
USD 80,00
+41,5%
09/29/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
08/05/2026
Evan Stampler
Wells Fargo
Buy
Maintained
USD 55,00
-2,7%
08/05/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
USD 55,00
-2,7%
08/05/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
USD 50,00
-11,6%
08/05/2026
Patrick B Donnelly
Citi
Hold
Maintained
USD 53,00
-6,3%
08/05/2026
Kyle Boucher
TD Cowen
Hold
Maintained
USD 60,00
+6,1%
08/04/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Dan Leonard
RBC Capital
Hold
Reiterated
USD 45,00
-20,4%
05/07/2026
Tycho Peterson
Jefferies
Buy
Maintained
USD 50,00
-11,6%
02/12/2026
Last report
04 Aug. 2026
Fiscal period
Q2 2026
USD 0,49 / USD 0,38
+27,49%beat
Revenue / Est. (USD)
838,50 m / 853,57 m
-1,77%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
860,50 m
977,20 m
823,40 m
838,50 m
Cost of goods sold
446,30 m
510,40 m
428,20 m
421,40 m
Cost of revenue
446,30 m
510,40 m
428,20 m
421,40 m
Research and development expenses
98,30 m
99,60 m
101,30 m
94,30 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
242,50 m
244,20 m
242,10 m
238,90 m
Operating expense
302,70 m
402,50 m
344,30 m
334,30 m
Total operating expenses
749,00 m
912,90 m
772,50 m
755,70 m
Operating income
111,50 m
64,30 m
50,90 m
82,80 m
Other non operating income
9,30 m
-5,70 m
3,00 m
4,00 m
EBT including unusual items
-72,60 m
67,00 m
18,20 m
-36,70 m
EBT excluding unusual items
106,60 m
54,20 m
47,30 m
87,90 m
Income tax expense
-14,10 m
37,80 m
2,50 m
14,20 m
Effective tax rate
19,42%
56,42%
13,74%
-38,69%
Other operating expenses
-38,10 m
58,70 m
800,00 k
1,10 m
Net income
-59,60 m
26,00 m
14,40 m
-52,00 m
Net profit margin
-6,93%
2,66%
1,75%
-6,20%
Earnings per share
0,45
0,59
0,31
0,49
Interest and investment income
4,40 m
4,60 m
4,90 m
11,30 m
Interest expense
-20,30 m
-11,20 m
-12,20 m
-17,80 m
Net interest expenses
-15,90 m
-6,60 m
-7,30 m
-6,50 m
Depreciation and amortization charges
-
-
-
-
EBITDA
167,20 m
122,40 m
109,20 m
140,80 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme